All Blogs

Apr 22, 2021

Vertex leads in CRISPR Therapeutics deal; Update for Phase 2 clinical trial of KVD824; Ovid dumps lead program; Virta Health pulls in $133M


Apr 21, 2021

Which Pharma Companies are Working to Mitigate the Burden of Digestive Disorders?


Apr 20, 2021

Adagio Raises $336 M; Lyndra’s Schizo Trial; BMS Opdivo for Gastric Cancer; Anixa Ovarian Cancer CAR-T Therapy


Feb 12, 2025

Exploring the Current Alzheimer’s Disease Drug Development Pipeline


Apr 16, 2021

Ewing Sarcoma: Key Companies and Emerging Therapies in the Landscape


Apr 15, 2021

Lilly’s Retevmo shows promise; CeQur tanks up on $110M in funding; Repertoire secures $189M; Recursion sets terms for $306M IPO


Apr 14, 2021

Sleep Disorders: An Emerging Public Health Issue


Apr 13, 2021

Taysha Acquires Rare Disease Gene Therapy For $5.5 M; AZ’s Farxiga Fails In COVID-19 Study; Sanofi To Strengthen Its Vaccines Manufacturing Capacities


Apr 12, 2021

Alpha-1 Antitrypsin Deficiency: Symptoms, Treatments and Key Companies in the Market


Apr 09, 2021

Limited Therapeutics Options and A Weak Pipeline: What Lies Ahead in the Cancer Anorexia Market?